Navigated micropulse laser for central serous chorioretinopathy: Efficacy, safety, and predictive factors of treatment response.
Francesca AmorosoAlexandre PedinielliSalomon Yves CohenCamille JungSumit Randhir SinghPolina AstrozDonato ColantuonoOudy SemounVittorio CapuanoEric H SouiedAlexandra MierePublished in: European journal of ophthalmology (2021)
Navigated micropulse laser laser treatment was found to be effective and safe for the treatment of chorioretinopathy, with significant improvement in visual and anatomical outcomes, unaccompanied by any adverse event at 3 and 6 months follow-up. Factors associated to subretinal fluid resolution may allow a better selection of likely responders to navigated micropulse laser treatment.